INVESTOR RELATIONS

Media Kit

image

Investor Presentation

Download our latest presentation.

image

Corporate Overview

Eterna Therapeutics discovers and develops new medicines utilizing mRNA cell engineering.

image

Platform Technologies

Eterna Therapeutics’ team of scientists and physicians are pioneers in using synthetic mRNA, cell reprogramming, gene editing, and other cutting-edge technologies.

image

Pipeline

Eterna is pursuing the development of advanced cell engineering therapies to address a range of therapeutic indications.

image

Leadership Team

We are a team of scientists and physicians who are committed to transforming patients’ lives.

image

Corporate Logos

Download our logos in a variety of formats. You may use these assets only for editorial news distribution. For non-editorial uses, please request permission.

Media & Investor Relations

Jon Yu
ICR Westwicke
475-395-5375
EternaPR@westwicke.com

Mailing Adress

1035 Cambridge St Ste 18A
Cambridge, MA 02141